Nishiguchi et al. [57] found that c-Met, HMGB1, and protocadherin beta 9 (PCDHB9) genes were differentially expressed in sensitive and drug-resistant cases of advanced gastric cancer, and their expression levels were negatively correlated with cisplatin (CDDP) sensitivity. Here, PCDHB9 is linked to gastric cancer.